Comment
. 2008 Feb 7;358(6):642; author reply 643.
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer
- PMID: 18265440
Item in Clipboard
Comment
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer
N Engl J Med.
.
No abstract available
Comment on
-
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.N Engl J Med. 2007 Oct 18;357(16):1579-88. doi: 10.1056/NEJMoa071430. N Engl J Med. 2007. PMID: 17942871 Clinical Trial.
Similar articles
-
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.N Engl J Med. 2008 Feb 7;358(6):642; author reply 643. N Engl J Med. 2008. PMID: 18265441 No abstract available.
-
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.N Engl J Med. 2008 Feb 7;358(6):641-2; author reply 643. N Engl J Med. 2008. PMID: 18265439 No abstract available.
-
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.N Engl J Med. 2008 Feb 7;358(6):642-3; author reply 643-4. N Engl J Med. 2008. PMID: 18265442 No abstract available.
-
HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. doi: 10.1016/S0020-7292(06)60039-8. Int J Gynaecol Obstet. 2006. PMID: 17161163 Review. No abstract available.
-
Cervical cancer screening from Pap smear to human papillomavirus DNA testing.Compr Ther. 2001 Fall;27(3):202-8. doi: 10.1007/s12019-001-0015-3. Compr Ther. 2001. PMID: 11569320 Review.
Cited by
-
Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort.BMJ Open. 2022 Oct 17;12(10):e063622. doi: 10.1136/bmjopen-2022-063622. BMJ Open. 2022. PMID: 36253033 Free PMC article.